Stock Code: Zhejiang Dayang Biotech Group Co.Ltd(003017) stock abbreviation: Zhejiang Dayang Biotech Group Co.Ltd(003017) Announcement No.: 2022021 Zhejiang Dayang Biotech Group Co.Ltd(003017)
Announcement on the progress of repurchasing shares of the company
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
1、 Overview of repurchase
Zhejiang Dayang Biotech Group Co.Ltd(003017) (hereinafter referred to as “the company”) deliberated and adopted the proposal on share repurchase of the company at the 28th meeting of the 4th board of directors held on November 25, 2021. See details disclosed by the company in China Securities Journal, securities times, securities daily and cninfo.com（ http://www.cn.info.com.cn. ）Announcement on share repurchase scheme of the company (Announcement No.: 2021117) and report on share repurchase (Announcement No.: 2021126).
On January 28, 2022, the Company repurchased shares for the first time by means of centralized bidding trading through a special securities repurchase account. For details, see the company’s disclosure in China Securities News, securities times, securities daily and cninfo（ http://www.cn.info.com.cn. ）Announcement on initial repurchase of shares of the company (Announcement No.: 2022005).
On January 5, February 8 and March 3, 2022, the company disclosed the announcement of repurchase progress as of December 31, 2021, January 31, 2022 and February 28, 2022 respectively. For details, see the company’s disclosure in China Securities Journal, securities times, securities daily and Juchao information network（ http://www.cn.info.com.cn. ）Announcement on the progress of repurchasing shares of the company (Announcement No.: 2022001, 2022006, 2022018).
2、 Repurchase progress
According to the relevant provisions of Shenzhen Stock Exchange self regulatory guidelines for listed companies No. 9 – share repurchase, the listed company shall announce the repurchase progress as of the end of last month within the first three trading days of each month during the repurchase period. The company’s repurchase progress by the end of last month is now announced as follows:
As of March 31, 2022, the company has repurchased 587900 shares of the company’s shares through the special securities repurchase account through centralized bidding transaction, accounting for 0.9798% of the company’s total share capital. The maximum transaction price is 35.01 yuan / share, the minimum transaction price is 33.49 yuan / share, and the cumulative transaction amount is 2025960600 yuan (excluding transaction costs). This repurchase meets the requirements of relevant laws and regulations and the company’s established repurchase plan.
3、 Other instructions
The time for the company to repurchase shares, the number of shares repurchased, the price of shares repurchased and the entrusted period of centralized bidding comply with the relevant provisions of Articles 17, 18 and 19 of the guidelines for self discipline supervision of listed companies on Shenzhen Stock Exchange No. 9 – share repurchases.
1. The company did not repurchase shares during the following periods:
(1) If the announcement date is delayed due to special reasons within 10 trading days before the announcement of the company’s annual report and semi annual report, it shall be calculated from the 10 trading days before the original scheduled announcement date;
(2) Within ten trading days before the announcement of the company’s quarterly report, performance forecast and performance express;
(3) From the date of occurrence of major events that may have a significant impact on the trading price of the company’s shares or in the process of decision-making to the date of disclosure according to law;
(4) Other circumstances prescribed by the CSRC.
2. Since the date when the company implements the share repurchase plan, the number of shares repurchased by the company every five trading days does not exceed 25% (i.e. 5222909 shares) of the cumulative trading volume of 20891639 shares in the five trading days before the date of the first share repurchase (January 28, 2022).
3. The repurchase of shares by the company through centralized bidding transaction meets the following requirements:
(1) The entrustment price shall not be the price limited by the trading increase of the company’s shares on the same day;
(2) The entrustment of share repurchase shall not be carried out within the opening call auction of Shenzhen Stock Exchange, half an hour before the closing and within the trading day when there is no limit on the rise or fall of the stock price;
(3) Other requirements stipulated by the CSRC and the Shenzhen Stock Exchange.
The company will implement the repurchase plan within the repurchase implementation period according to the market conditions, and timely perform the obligation of information disclosure in accordance with the provisions of relevant laws and regulations.
It is hereby announced.
Zhejiang Dayang Biotech Group Co.Ltd(003017) board of directors April 6, 2022
